Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 30,000 shares at $19.06 ($576K) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Open-market sale of $576k PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.33 | 15,000 | $290K | 50.4% |
| 2 | $19.06 | 15,000 | $286K | 49.6% |
| Total | $19.20 avg | 30,000 | $576K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |